Skip to main content

MicroRNAs in tumor cells

DNA logic nanomachine for the accurate identification of multiple microRNAs in tumor cells


The use of dynamic DNA logic circuits for disease diagnosis at the molecular level plays a considerable role in biomedical fields. Nevertheless, how to create programmable nanomachines based on molecular logical gates to accurately identify multiple biomarkers from tumor cells remains a pivotal challenge. Herein, we developed a DNA-based nanomachine for analyzing and imaging multiple microRNAs (miRNAs) in cancerous cells with a logical AND operation. The triangular prism design of DNA nanomachine improved its performance in living cell research with high stability and served as a modularized framework for toehold-mediated strand displacement reactions and catalytic hairpin assembly circuits.

The results suggested that the nanomachine could efficiently enter cells with great biocompatibility and rapidly recognize the correct biomolecules with high sensitivity. The well-designed DNA-logic gate nanomachine enabled accurate diagnosis on multiple miRNA patterns in different cell lines and differentiation of aberrant expression in target cells, which provided a novel possibility for intelligent disease diagnosis using smart nanomachines at the molecular level.

Chemicals and materials


The sequences of synthesized oligonucleotides are listed in Table S1, the reagents and materials in the experiments are described in the Supplementary Material.

DNA prism probe was prepared through adding equimolar nucleic acid strands of S1, S2, S3, H1-T, H2-T/H2-T-FQ, Capture-T, Trigger, Apt-1, Apt-2 and Apt-3 in 1 × TAE-Mg2+ buffer (40 mM Tris buffer, 1 mM EDTA, 12.5 mM MgAc2, pH 8.0) to the final concentration of 1 μM. The mixture was then subjected to a thermal annealing process (Table S2)

The working principle of self-assembled DNA nanomachines for simultaneous identification and imaging of multi-miRNAs is exhibited in Scheme 1. Initially, the 3D DNA nanomachine was one-pot self-assembled from ten nucleic acid strands, of which three long strands (S1, S2, S3) for assembling the triangular prism framework, two strands (Capture-T and Trigger) for synthesizing an “Anchor” domain to identify target miRNAs, two hairpin strands (H1-T and H2-T) as CHA substrate strands, and three.

In this work, DNA-logic gate nanomachines activated by multi-target miRNAs within cells were successfully designed using a DNA triangular prism as the nano-vehicle and the CHA cascade circuit as a signal amplifier. After internalization, DNA nanomachines made logical responses and the Trigger strand could be efficiently released via TMSD in the presence of miRNA-21, miRNA-155, and miRNA-10b simultaneously. Whereafter, CHA was activated by dissociative Trigger strand to generate amplified.

tumor microenvironment, cancer stem cells, metastasis, angiogenesis, immune evasion, oncogenes, tumor suppressor genes, apoptosis resistance, epithelial-mesenchymal transition, tumor heterogeneity, cell proliferation, hypoxia, tumor markers, neoplastic transformation, chemotherapy resistance, cell signaling pathways, tumorigenesis, genomic instability, cancer immunotherapy, tumor metabolism

#TumorCells, #CancerResearch, #Oncology, #Metastasis, #TumorMicroenvironment, #CancerStemCells, #TumorImmunology, #CancerTherapy, #ApoptosisResistance, #TumorMarkers, #Angiogenesis, #CellProliferation, #CancerGenetics, #EMT, #TumorHeterogeneity, #TumorMetabolism, #Chemoresistance, #PrecisionOncology, #CancerSignaling, #GenomicInstability

International Conference on Genetics and Genomics of Diseases

Visit: genetics-conferences.healthcarek.com

Award Nomination: genetics-conferences.healthcarek.com/award-nomination/?ecategory=Awards&rcategory=Awardee

Award registration: genetics-conferences.healthcarek.com/award-registration/

For Enquiries: contact@healthcarek.com

Get Connected Here
---------------------------------
---------------------------------
in.pinterest.com/Dorita0211
twitter.com/Dorita_02_11_
facebook.com/profile.php?id=61555903296992
instagram.com/p/C4ukfcOsK36
genetics-awards.blogspot.com/
youtube.com/@GeneticsHealthcare

Comments

Post a Comment

Popular posts from this blog

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...
Post a Comment
Read more

Post-Stroke Cardiovascular risks

Study finds genetic factors key to post-stroke cardiovascular risks In a recent study published in the journal Stroke , researchers identify genetic and molecular risk factors for subsequent cardiovascular outcomes after incident stroke in an effort to identify potential therapeutic targets to improve patient prognoses. Identifying the causes of stroke Stroke is a major global health issue that causes significant disability and mortality, particularly arterial ischemic stroke (AIS). AIS, which is a type of stroke caused by blocked blood flow to the brain, is responsible for up to 85% of stroke cases. AIS arises due to cerebral blood vessel blockage, with modifiable risk factors including hypertension, diabetes, dyslipidemia, atrial fibrillation, obesity, and lifestyle behaviors. Although genome-wide association studies (GWAS) often focus on incident strokes, studying subsequent events can provide new insights into stroke progression. Further research is crucial to identify genetic and...
Post a Comment
Read more

Type of Inherited Blindness in Dogs

Genetic test could eradicate a type of inherited blindness in dogs A mountain rescue dog whose duties ended after her eyesight failed has helped scientists create a test that could eradicate the genetic eye condition in her breed for good. Shola the English shepherd has an inherited eye disease called progressive retinal atrophy (PRA) that causes the light-sensitive cells at the back of the eye to deteriorate, eventually leading to blindness. PRA affects more than 100 dog breeds, can be caused by a number of different genetic variants and has no treatment. For some types, symptoms do not appear until the dog is several years old , by which point they may have passed their genes on to puppies. Katherine Stanbury, the first author of the research from the University of Cambridge, said Shola was four years old when she began struggling with her vision in dim light. “She was sent to a veterinary ophthalmologist and they confirmed that she had PRA,” said Stanbury. “And then it turned out h...
Post a Comment
Read more